Comments
Loading...
Marinus Pharma (MRNS) Forecast
NewsEarningsMarinus Pharma (MRNS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMarinus Pharma (NASDAQ:MRNS) Stock Quotes, Forecast and News Summary
Marinus Pharma Stock (NASDAQ: MRNS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Marinus Pharma (MRNS) stock?
You can purchase shares of Marinus Pharma (NASDAQ:MRNS) through any online brokerage.
Who are Marinus Pharma (MRNS) competitors?
Other companies in Marinus Pharma’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Jaguar Health (NASDAQ:JAGX) and Redhill Biopharma (NASDAQ:RDHL).
What is the forecast, or price target, for Marinus Pharma (MRNS) stock?
Marinus Pharma has a consensus price target of $5.86.
What is the current price for Marinus Pharma (MRNS)?
The stock price for Marinus Pharma (NASDAQ: MRNS) is $0.2471 last updated December 18, 2024 at 9:12 AM EST.
Does Marinus Pharma (MRNS) pay a dividend?
There are no upcoming dividends for Marinus Pharma.
When is Marinus Pharma (NASDAQ:MRNS) reporting earnings?
Marinus Pharma’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
Is Marinus Pharma (MRNS) going to split?
There is no upcoming split for Marinus Pharma.
What sector and industry does Marinus Pharma (MRNS) operate in?
Marinus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.